Actively Recruiting
Drug-Coated Coronary Balloons in Different Clinical Scenarios
Led by Kutahya Health Sciences University · Updated on 2026-01-13
1500
Participants Needed
5
Research Sites
52 weeks
Total Duration
On this page
Sponsors
K
Kutahya Health Sciences University
Lead Sponsor
P
Pamukkale University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Coronary stents are the best treatment method ever accepted in the treatment of coronary artery stenoses. Due to some limitations and complications of stent use, the operators tried to find new solutions. Drug Coated Balloons (DCBs) have been accepted as a new method in the treatment of in-stent restenosis and small vessel disease. Furthermore, they have been used in the treatment of de novo coronary lesions, chronic total occlusions and bifucation lesions. But data is limited in the short and long term success of DCBs in all these clinical scenarios. In our study we aimed to investigate the procedural success and short and long term outcomes of DCB use in different clinical scenarios.
CONDITIONS
Official Title
Drug-Coated Coronary Balloons in Different Clinical Scenarios
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with coronary artery disease undergoing PCI using a drug-coated balloon for at least one lesion
- DCB use allowed in stable coronary artery disease and acute coronary syndromes
- DCB treatment for lesion types including de novo, in-stent restenosis, bifurcation, small and large vessels, and chronic total occlusions
- Successful lesion preparation with residual stenosis 30% or less and no flow-limiting dissection before DCB inflation
- Availability of baseline clinical, angiographic, and procedural data
- Ability to provide informed consent for prospective or data availability for retrospective enrollment
- Planned clinical follow-up
You will not qualify if you...
- Treatment without use of a drug-coated balloon (e.g., only drug-eluting stent implantation)
- Cardiogenic shock at the time of the procedure
- Life expectancy under 1 year due to non-cardiac conditions
- Contraindication to antiplatelet therapy
- Known severe allergy to contrast media not treatable by premedication
- Pregnancy
- Inability to comply with clinical follow-up
- Participation in another interventional clinical trial that may affect outcomes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Pamukkale University
Denizli, Turkey (Türkiye)
Actively Recruiting
2
Bahcelievler Memorial Hospital
Istanbul, Turkey (Türkiye)
Actively Recruiting
3
Bezmialem Vakıf Universitesi
Istanbul, Turkey (Türkiye)
Actively Recruiting
4
Goztepe Medicalpark Hastanesi
Istanbul, Turkey (Türkiye)
Actively Recruiting
5
Kutahya City Hospital
Kütahya, Turkey (Türkiye)
Actively Recruiting
Research Team
F
Fatih Kahraman, Associate Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here